Showing 1 - 10 of 709
We study the effect of the COVID-19 pandemic and the associated government measures on individual mobility choices in Switzerland. Our data is based on over 1,000 people for which we observe all trips during eight weeks before the pandemic and again for up to 6 months after its onset. We find an...
Persistent link: https://www.econbiz.de/10013269293
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...
Persistent link: https://www.econbiz.de/10012658132
We study the effect of the COVID-19 pandemic and the associated government measures on individual mobility choices in Switzerland. Our data is based on over 1,600 people for which we observe all trips during eight weeks before the pandemic and until May 2021. We find an overall reduction of...
Persistent link: https://www.econbiz.de/10014374410
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...
Persistent link: https://www.econbiz.de/10012585215
We study the effect of the COVID-19 pandemic and the associated government measures on individual mobility choices in Switzerland. Our data is based on over 1,000 people for which we observe all trips during eight weeks before the pandemic and again for up to 6 months after its onset. We find an...
Persistent link: https://www.econbiz.de/10012661098
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...
Persistent link: https://www.econbiz.de/10012585624
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...
Persistent link: https://www.econbiz.de/10012589862
We study the effect of the COVID-19 pandemic and the associated government measures on individual mobility choices in Switzerland. Our data is based on over 1,600 people for which we observe all trips during eight weeks before the pandemic and until May 2021. We find an overall reduction of...
Persistent link: https://www.econbiz.de/10013490708
Strict containment limits the spread of pandemics but is difficult to achieve when people must continue to work to avoid poverty. A new role is emerging for income support: by enabling people to effectively stay home, it can produce substantial health externalities. We examine this issue using...
Persistent link: https://www.econbiz.de/10012882543
This study carries out a cross-country analysis of changes in quantity and quality of life during the first six months of the COVID-19 pandemic (11 March to 11 September 2020) for 124 countries. Changes in quantity of life are measured as life years lost to COVID-19, including excess deaths not...
Persistent link: https://www.econbiz.de/10013162467